MAPK3 and cholangiocarcinoma: In patients with cholangiocarcinoma (CCA) who have lymph node metastasis (LNM), cancer-associated fibroblasts (CAFs) promote lymphangiogenesis by activating the ERK1/2-JNK pathway in LECs through the secretion of PDGF-BB (Yan et al., 2024).